IP Library Granted Patent US 10,369,492
Granted Patent B2
US 10,369,492 · App. 15/743,115 · Granted Aug 6, 2019

Process for the isolation of levulinic acid

Inventors: Aris De Rijke (Geleen, NL); Rudy Francois Maria Jozef Parton (Geleen, NL); Donato Santoro (Valletta, MT)
Assignee: GFBIOCHEMICALS IP ASSETS B.V.
B01D3/009B01D1/26C07C51/44B01D2257/70C07C59/185
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,492
App. No.
15/743,115
Granted
Aug 6, 2019
Kind
B2
Abstract

A process for the isolation of levulinic acid obtained by acid catalyzed hydrolysis of a C6-carbohydrate-containing feedstock, including the following steps: a) providing a solution 1 comprising at least 5 wt. % of levulinic acid, at least 0.1 wt. % of formic acid and at most 94.9 wt. % of solvent, relative to the total weight of solution 1, b) feeding solution 1 to a first evaporation step to treat solution 1 and to obtain solution 2, comprising at least 25 wt. % of levulinic acid, less than 20 wt. % of solvent and at least 1 wt. % of formic acid, relative to the total weight of solution 2, c) feeding solution 2 to a second evaporation step to treat solution 2 and to obtain solution 3, comprising at least 30 wt. % of levulinic acid and less than 1.0 wt. % of formic acid, relative to the total weight of solution 3, d) feeding solution 3 to a third evaporation step to treat solution 3 and to obtain levulinic acid with a purity of at least 90 wt. % and containing less than 1000 wppm angelica lactone.

Claims (22)

1. A process for the isolation of levulinic acid obtained by acid catalyzed hydrolysis of a C6-carbohydrate-containing feedstock, comprising the following steps:

a) providing a solution 1 comprising at least 5 wt. % of levulinic acid, at least 0.1 wt. % of formic acid and at most 94.9 wt % of solvent, relative to the total weight of solution 1,

b) feeding solution 1 to a first evaporation step to treat solution 1 and to obtain solution 2, comprising at least 25 wt. % of levulinic acid, less than 20 wt. % of solvent and at least 1 wt. % of formic acid, relative to the total weight of solution 2,

c) feeding solution 2 to a second evaporation step to treat solution 2 and to obtain solution 3, comprising at least 30 wt. % of levulinic acid and less than 1.0 wt. % of formic acid the total weight of solution 3,

d) feeding solution 3 to a third evaporation step to treat solution 3 and to obtain levulinic acid with a purity of at least 90 wt. % and containing less than 1000 wppm angelica lactone.

2. The process according to claim 1 , wherein each of steps c and d is performed in 1 evaporator or 2 evaporators.

3. The process according to claim 1 , wherein the evaporator or evaporators in the evaporation steps are operated at a liquid temperature between 100 and 200° C.

4. The process according to claim 1 , wherein the evaporator or evaporators in step b are operated at a pressure between 5-500 kPa.

5. The process according to claim 1 , wherein the evaporator or evaporators in step c are operated at a pressure between 1-20 kPa.

6. The process according to claim 1 , wherein the evaporator or evaporators in step d are operated at a pressure between 0.1-7.5 kPa.

7. The process according to claim 1 , wherein one evaporator is present in each evaporation step and the evaporator in the first evaporation step is a forced circulation evaporator, the evaporator in the second evaporation step is a first agitated film evaporator and the evaporator in the third evaporation step is a second agitated thin film evaporator.

8. The process according to claim 1 , wherein levulinic acid in solution 1 is present in an amount of at least 10 wt. %, relative to the total weight of solution 1.

9. The process according to claim 1 , wherein the isolation process is a continuous process.

10. The process according to claim 1 , wherein the solvent is water.

11. The process according to claim 1 , wherein in solution 1 the levulinic acid is present in an amount of at most 60 wt. %.

12. The process according to claim 1 , wherein during purification of reaction product X in step a no liquid-liquid extraction is used.

13. The process according to claim 12 , wherein

a) solution 1 is fed to a forced circulation operated at a pressure between 5-500 kPa and at a liquid temperature between 100 and 200° C.,

b) solution 2 is fed to a first agitated thin film evaporator operated at a pressure between 1-20 kPa and at a liquid temperature between 100 and 200° C. and

c) solution 3 is fed to a second agitated thin film evaporator operated at a pressure between 0.1-7.5 kPa and at a liquid temperature between 100 and 200° C.

14. The process according to claim 3 , wherein the evaporator or evaporators in step b are operated at a pressure between 5-500 kPa, wherein the evaporator or evaporators in step c are operated at a pressure between 1-20 kPa, wherein the evaporator or evaporators in step d are operated at a pressure between 0.1-7.5 kPa, and wherein one evaporator is present in each evaporation step and the evaporator in the first evaporation step is a forced circulation evaporator, the evaporator in the second evaporation step is a first agitated film evaporator and the evaporator in the third evaporation step is a second agitated thin film evaporator.

15. The process according to claim 14 , wherein levulinic acid in solution 1 is present in an amount of at least 10 wt. %, relative to the total weight of solution 1, wherein the isolation process is a continuous process, wherein the solvent is water, wherein in solution 1 the levulinic acid is present in an amount of at most 60 wt. %, and wherein during purification of reaction product X in step a no liquid-liquid extraction is used.

Assignments (2)
CHANGE OF NAME Recorded Mar 30, 2018
From: GFBIOCHEMICALS LTD
To: GFBIOCHEMICALS IP ASSETS B.V.
Reel/Frame 045788/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2018
From: DE RIJKE, ARIS; PARTON, RUDY FRANCOIS MARIA JOZEF
To: GFBIOCHEMICALS LTD
Reel/Frame 045357/0370 →
Priority Claims (1)
EP 15176315 · Jul 10, 2015 · regional
Continuity (1)
Related Publication 20190099691A1 · Apr 4, 2019